Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:FVR NASDAQ:MITA NASDAQ:OACC NASDAQ:PLMK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFVRFrontView REIT$13.43+1.4%$12.29$10.61▼$19.76$274.78MN/A208,014 shs70,858 shsMITAColiseum Acquisition$11.51$11.51$9.00▼$13.70$63.73M0.0322,942 shsN/AOACCOaktree Acquisition Corp. III Life Sciences$10.45+0.1%$10.45$9.95▼$10.85$234.34MN/A101,918 shs65,178 shsPLMKPlum Acquisition Corp. IV$10.29+0.1%$10.28$9.94▼$10.34$249.46MN/A108,230 shs109 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFVRFrontView REIT-1.42%+2.06%+3.61%+16.93%+1,328,299,900.00%MITAColiseum Acquisition0.00%0.00%0.00%0.00%+3.88%OACCOaktree Acquisition Corp. III Life Sciences+0.10%+0.68%-0.29%0.00%+1,043,999,900.00%PLMKPlum Acquisition Corp. IV+0.10%0.00%-0.29%+1.18%+1,027,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFVRFrontView REIT1.657 of 5 stars2.10.02.50.02.11.70.6MITAColiseum AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/AN/AN/APLMKPlum Acquisition Corp. IVN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFVRFrontView REIT 2.20Hold$15.1012.43% UpsideMITAColiseum Acquisition 0.00N/AN/AN/AOACCOaktree Acquisition Corp. III Life Sciences 0.00N/AN/AN/APLMKPlum Acquisition Corp. IV 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest MITA, PLMK, FVR, and OACC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/11/2025FVRFrontView REITMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Equal Weight$13.506/17/2025FVRFrontView REITBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Underperform$15.00 ➝ $11.006/17/2025FVRFrontView REITJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral$14.00 ➝ $12.006/10/2025FVRFrontView REITJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$15.00 ➝ $14.00(Data available from 8/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFVRFrontView REIT$66.68M4.12$0.50 per share26.73$24.63 per share0.55MITAColiseum AcquisitionN/AN/A$0.37 per share31.40($0.69) per shareN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/APLMKPlum Acquisition Corp. IVN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFVRFrontView REIT-$22.21M-$1.07N/A11.29N/A-43.21%-5.48%-3.33%11/12/2025 (Estimated)MITAColiseum Acquisition$3.10MN/A0.00∞N/AN/A-16.55%-9.51%N/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/A0.00∞N/AN/AN/AN/AN/APLMKPlum Acquisition Corp. IVN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFVRFrontView REIT$0.866.40%N/AN/A N/AMITAColiseum AcquisitionN/AN/AN/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/APLMKPlum Acquisition Corp. IVN/AN/AN/AN/AN/ALatest MITA, PLMK, FVR, and OACC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/14/2025FVRFrontView REITquarterly$0.21506.9%9/30/20259/30/202510/15/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFVRFrontView REIT0.630.730.73MITAColiseum AcquisitionN/A0.010.01OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/APLMKPlum Acquisition Corp. IVN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFVRFrontView REITN/AMITAColiseum Acquisition25.79%OACCOaktree Acquisition Corp. III Life SciencesN/APLMKPlum Acquisition Corp. IVN/AInsider OwnershipCompanyInsider OwnershipFVRFrontView REIT4.30%MITAColiseum Acquisition47.70%OACCOaktree Acquisition Corp. III Life SciencesN/APLMKPlum Acquisition Corp. IVN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFVRFrontView REITN/A20.46 million19.58 millionN/AMITAColiseum Acquisition2,0215.54 million3.35 millionNot OptionableOACCOaktree Acquisition Corp. III Life SciencesN/A22.43 millionN/AN/APLMKPlum Acquisition Corp. IV224.24 millionN/AN/AMITA, PLMK, FVR, and OACC HeadlinesRecent News About These CompaniesKepos Capital LP Takes $502,000 Position in Plum Acquisition Corp. IV (NASDAQ:PLMK)August 15, 2025 | marketbeat.comVirtu Financial LLC Takes $694,000 Position in Plum Acquisition Corp. IV (NASDAQ:PLMK)August 14, 2025 | marketbeat.comMizuho Securities USA LLC Acquires New Position in Plum Acquisition Corp. IV (NASDAQ:PLMK)August 13, 2025 | marketbeat.com340,182 Shares in Plum Acquisition Corp. IV (NASDAQ:PLMK) Purchased by Wolverine Asset Management LLCAugust 10, 2025 | marketbeat.comPicton Mahoney Asset Management Makes New $1.51 Million Investment in Plum Acquisition Corp. IV (NASDAQ:PLMK)July 30, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMITA, PLMK, FVR, and OACC Company DescriptionsFrontView REIT NYSE:FVR$13.43 +0.19 (+1.44%) Closing price 03:59 PM EasternExtended Trading$13.43 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FrontView REIT specializes in real estate investing.Coliseum Acquisition NASDAQ:MITAColiseum Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Las Vegas, Nevada.Oaktree Acquisition Corp. III Life Sciences NASDAQ:OACC$10.45 +0.01 (+0.10%) As of 03:29 PM EasternOaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.Plum Acquisition Corp. IV NASDAQ:PLMK$10.29 +0.01 (+0.10%) As of 02:53 PM EasternPlum Acquisition Corp. IV is a blank check company, which was established for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on June 10, 2024 and is headquartered in San Francisco, CA. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Williams-Sonoma Q2 Results Prove Its Buy-and-Hold Quality Okta: Market Comes to a Boil, Explosive Upside Is Possible MongoDB Roars Back to Life: It’s Not Too Late to Buy More Vertical Aerospace: An Analyst's Roadmap to a Potential Re-Rating AEHR Spikes 36% on Hyperscaler Order—Investors Should Take Notice From Debt to Liftoff: EchoStar's $23 Billion Catalyst Buffett’s Wisdom Could Spell Trouble for Palantir Shorts Tesla Just Had Its Best Day in 2 Months—Here’s What It Means Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access